DRI searches Cipla's Mumbai office, Bhiwandi depot over imported drugs

The Directorate of Revenue Intelligence's Mumbai zonal unit has searched Cipla's office in Vikhroli and its depot in Bhiwandi over the classification or exemption of an imported pharmaceutical finished product. Cipla said it cooperated with author...

New Delhi: The Directorate of Revenue Intelligence (DRI), Mumbai zonal unit, has conducted search proceedings at Cipla's office in Vikhroli and its depot in Bhiwandi, Thane, over the classification or exemption of an imported pharmaceutical finished product.

In a regulatory filing under Regulation 30 of the SEBI Listing Regulations, the company said the search was conducted on Monday under Section 105 of the Customs Act, 1962.

According to the filing, "the search is related to the classification or exemption of an imported pharmaceutical finished product."


The pharmaceutical company said it extended full cooperation and assistance to the authorities during the proceedings.

The company further said there is no material impact on its financials, operations, or other activities due to the search.

Shares of Cipla were trading at Rs 1,390.70, down 0.24 per cent on BSE.
READ MORE
ADVERTISEMENT

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › Industry › Healthcare/Biotech › Pharmaceuticals › DRI searches Cipla's Mumbai office, Bhiwandi depot over imported drugs
Text Size:AAA
Success
This article has been saved

*

+